InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.
12 mars 2021 08h17 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
11 févr. 2021 08h00 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn. and DEERFIELD, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
FluroTech Announces Appointment of Regulatory Consultant
14 janv. 2021 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 14, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce it has retained PandiaDx LLC (“PandiaDX”) for...
FluroTech Announces Closing of First Tranche of Private Placement
11 janv. 2021 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 11, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is very pleased to announce that it has closed the first tranche of a...
FluroTech Announces Exploration of Strategic Options for Cannabis Testing Business to Focus on Pandemic Defense System
18 déc. 2020 18h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Dec. 18, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is exploring strategic alternatives for its Cannabis and Hemp testing...
FluroTech Announces Stadium and Arena Product Solution
17 nov. 2020 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 17, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
FluroTech Announces Joint Venture SARS-CoV2 Test Method Optimization
12 nov. 2020 09h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 12, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that has begun optimization of its SARS-CoV2...
FluroTech Announces Joint Venture Product Solution and Partners
10 nov. 2020 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 10, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce, its previously announced joint venture...
FluroTech Formalizes Ownership Structure in FluroTest Joint Venture and Launches a Financing
05 nov. 2020 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 05, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest, LLC (the “LLC”), a company in...
FluroTech Announces Filing of Patent Applications With Respect to Its Proprietary Diagnostic Test Method and Pandemic Defense Platform
22 oct. 2020 09h04 HE
|
FluroTech Ltd.
CALGARY, Alberta, Oct. 22, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest LLC (“FluroTest”), a company in...